An electrochemical sensor based on an amino-functionalized iron NH2-MIL-101(Fe) metal-organic framework (MOF)/Pd nanoparticles (NPs) composite-modified screen-printed electrode (SPE) is prepared for the simultaneous determination of norepinephrine (NEPI) and acetaminophen (ACP). The NH2-MIL-101(Fe) MOF/Pd NPs/SPE electrochemical sensor shows a significant enhancement in the response peak current of NEPI, as compared to bare SPE. This suggests that the unique features of NH2-MIL-101(Fe) MOF/Pd NPs composite-modified SPE improve the electrocatalytic oxidation of NEPI. Such a synergistic effect between NH2-MIL-101(Fe) MOF and Pd NPs results in a significant enhancement in the response, where the MOF's high surface area combines with the high electron-transfer rate and the abundance of catalytically active sites afforded by the Pd NPs. The differential pulse voltammetry (DPV) method was obtained for quantitative determination of NEPI and high sensitivity was observed in NEPI determination with the calibration slope of 0.0327, µA µM-1. The developed NH2-MIL-101(Fe) MOF/Pd NPs/SPE sensor presents a low limit of detection of 0.007 µM toward NEPI determination. The developed NH2-MIL-101(Fe) MOF/Pd NPs/SPE sensor shows a good catalytic activity for the oxidation of NEPI and ACP, with anodic peak potentials of 360 and 550 mV, respectively. The separation of anodic peak potential is sufficient to enable simultaneous determination. Finally, the suggested sensing platform has confirmed suitable for the simultaneous determination of NEPI and ACP in real samples (pharmaceutical formulations and urine samples), achieving recovery values ranging from 97.1 to 104.4 % with relative standard deviations ≤3.6 %.
